Diagnocure CUR Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diagnocure CUR

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cal Gary who wrote (118)	3/29/2001 8:09:42 AM
From: Mr. L. Neufeldt	Read Replies (1) of 132

It's a start! Sales for this last quarter over a year ago are up @1800%. OK, we're dealing with small revenue buy I reiterate, it's a start. I'm led to believe that the sales increases are progressing slowly but surely. Sales appear to be continuing to increase as the industry accepts the test as a standard. Projections of $15 million/yr in sales within 5 years in the US appear well on their way. Not to much is said about European sales. Did you check the Octagon report? It's very well done and gives a conservative view of CUR's possibilities. A lot of CUR's success still hinges on the development of uPM3. We should have a deal for funding of studies and distribution within the next two to four months! I trust CUR will take a jump on this news regardless of the general market conditions or at least solidify with a higher base line.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next